Skip to main content
. 2016 Nov 30;8(13):20751–20765. doi: 10.18632/oncotarget.10612

Figure 1. NSUN2 levels in invasive breast cancers versus normal breast tissues or breast cancers in situ, according to the results found in Oncomine database.

Figure 1

A. NSUN2 levels in invasive breast cancers vs normal tissue samples. B. NSUN2 expression in invasive ductal breast cancers vs lobular breast carcinomas. C. NSUN2 expression levels in invasive ductal breast cancers vs ductal breast cancers in situ. D. NSUN2 levels in invasive lobular breast cancers vs invasive ductal breast cancers.